Evidence map›Paper›PMID 34069756›Full record

ArticleInternational journal of molecular sciences2021

Enhanced Activity and Sustained Release of Protocatechuic Acid, a Natural Antibacterial Agent, from Hybrid Nanoformulations with Zinc Oxide Nanoparticles.

Khaled AbouAitah, Urszula Piotrowska, Jacek Wojnarowicz, Anna Swiderska-Sroda, Ahmed H H El-Desoky, Witold Lojkowski

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Khaled AbouAitahLaboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska St. 29/37, 01-142 Warsaw, Poland.ORCID 0000-0001-8413-6738
Urszula PiotrowskaDepartment of Biomaterials Chemistry, Chair of Analytical Chemistry and Biomaterials, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha St., 02-097 Warsaw, Poland.ORCID 0000-0002-2418-9528
Jacek WojnarowiczLaboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska St. 29/37, 01-142 Warsaw, Poland.ORCID 0000-0002-6106-5188
Anna Swiderska-SrodaLaboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska St. 29/37, 01-142 Warsaw, Poland.
Ahmed H H El-DesokyPharmacognosy Department, Pharmaceutical Industries Research Division, National Research Centre, 33 El-Behouth St., Dokki, Giza 12622, Egypt.
Witold LojkowskiLaboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska St. 29/37, 01-142 Warsaw, Poland.ORCID 0000-0001-8521-0688
Institute of High Pressure Physics · PLMedical University of Warsaw · PLNational Research Centre · EG

Funding

European Regional Development Fund within the Operational Programme "Innovative Economy" for 2007-2013. CePT project (no. POIG.02.02.00-14-024/08)Institute of High-Pressure Physics, Polish Academy of Sciences (Poland) Institute fundNational Research Centre (Egypt) Available sources and devices
6 · The paper itself

Abstract

Hybrid nanostructures can be developed with inorganic nanoparticles (NPs) such as zinc oxide (ZnO) and natural antibacterials. ZnO NPs can also exert antibacterial effects, and we used them here to examine their dual action in combination with a natural antibacterial agent, protocatechuic acid (PCA). To produce hybrid nanoformulations, we functionalized ZnO NPs with four types of silane organic molecules and successfully linked them to PCA. Physicochemical assessment confirmed PCA content up to ~18% in hybrid nanoformulations, with a PCA entrapment efficiency of ~72%, indicating successful connection. We then investigated the in vitro release kinetics and antibacterial effects of the hybrid against

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsDelayed-Action PreparationsDrug Delivery SystemsEscherichia coliEscherichia coli InfectionsHydroxybenzoatesMetal NanoparticlesMicrobial Sensitivity TestsNanoparticlesNanostructuresStaphylococcal InfectionsStaphylococcus aureusZinc OxideAnti-Bacterial AgentsAnti-Infective AgentsDelayed-Action PreparationsHydroxybenzoatesprotocatechuic acidZinc Oxideantibacterial effectdelivery systemhybrid nanoformulationnatural agentsprotocatechuic acid prodrugStaphylococcus aureussustained releaseZnO nanoparticles

Identifiers

PMID34069756
PMCPMC8156785
OpenAlexW3163249577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.